MEDICAL CONDITION | SITE, N (%) | TOTAL COHORT (N = 102), N (%) | P VALUE | ||
---|---|---|---|---|---|
TORONTO (N = 44) | VANCOUVER (N = 36) | MONTREAL (N = 22) | |||
Hepatitis B | 0 (0) | 2 (6) | 2 (9) | 4 (4) | .111 |
Hepatitis C | 12 (27) | 22 (61) | 14 (64) | 48 (47) | .002* |
Syphilis | 0 (0) | 2 (6) | 0 (0) | 2 (2) | NA |
HIV | 0 (0) | 2 (6) | 0 (0) | 2 (2) | NA |
Zidovudine use during labour | 0 (0) | 8 (22) | 0 (0) | 8 (8) | NA |
NA—not applicable.
↵* Indicates significant difference at P < .05.